Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent
- PMID: 95247
- DOI: 10.3109/03602537908997471
Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent
Abstract
In conclusion, it was the differential responses of slow and rapid acetylators to procainamide therapy that gave the initial clues that acetylprocainamide might be a safer drug than procainamide. So far, the experience with acetylprocainamide has been encouraging.
Similar articles
-
Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.Drugs. 1990 May;39(5):720-40. doi: 10.2165/00003495-199039050-00007. Drugs. 1990. PMID: 1693889 Review.
-
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.Am J Cardiol. 1980 Sep;46(3):463-8. doi: 10.1016/0002-9149(80)90016-8. Am J Cardiol. 1980. PMID: 6158263 Clinical Trial.
-
Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.Angiology. 1986 Dec;37(12 Pt 2):968-71. Angiology. 1986. PMID: 2433971
-
Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.Angiology. 1986 Dec;37(12 Pt 2):930-8. Angiology. 1986. PMID: 2433967
-
[Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].Przegl Lek. 1984;41(5):379-83. Przegl Lek. 1984. PMID: 6206523 Review. Polish. No abstract available.
Cited by
-
Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.Drugs. 1990 May;39(5):720-40. doi: 10.2165/00003495-199039050-00007. Drugs. 1990. PMID: 1693889 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources